CEDARHURST, N.Y., Aug. 9, 2023 /PRNewswire/ — The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Apellis Pharmaceuticals, Inc. (NasdaqGS: APLS), if they purchased the Company’s shares between January 28, 2021 and July 28, 2023, inclusive (the…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.